We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

New test to Measure Effectiveness of Treatments for Huntington’s Disease

News   Aug 10, 2015

 
New test to Measure Effectiveness of Treatments for Huntington’s Disease
 
 
 

RELATED ARTICLES

FDA Approves First Treatment for Postpartum Depression

News

The U.S. Food and Drug Administration today approved Zulresso (brexanolone) injection for intravenous (IV) use for the treatment of postpartum depression (PPD) in adult women. This is the first drug approved by the FDA specifically for PPD.

READ MORE

Fast-acting Psychedelic Eases Depression and Anxiety

News

Researchers have discovered that use of the synthetic psychedelic, 5-methocy-N,-N-dimethyltryptamine, appears to be associated with unintended improvements in self-reported depression and anxiety when given in a ceremonial group setting.

READ MORE

Study Ties Common Heartburn Medications to Kidney Disease

News

Common medications prescribed to treat heartburn, acid reflux and ulcers are linked to increased risks for kidney failure and chronic kidney disease, found a recent University at Buffalo study.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE